Oil & Gas Exploration & Production
Build Your Comparison
Side-by-side financial analysisStock Comparison
VET vs XOM vs SLB vs HAL vs BKR
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Oil & Gas Equipment & Services
Oil & Gas Equipment & Services
Oil & Gas Equipment & Services
VET vs XOM vs SLB vs HAL vs BKR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Exploration & Production | Oil & Gas Integrated | Oil & Gas Equipment & Services | Oil & Gas Equipment & Services | Oil & Gas Equipment & Services |
| Market Cap | $1.71B | $623.01B | $84.33B | $33.07B | $62.62B |
| Revenue (TTM) | $1.81B | $323.90B | $35.71B | $22.17B | $27.89B |
| Net Income (TTM) | $-814M | $28.84B | $3.35B | $1.54B | $3.12B |
| Gross Margin | 35.9% | 21.7% | 18.2% | 15.3% | 23.6% |
| Operating Margin | 20.2% | 10.5% | 15.3% | 11.3% | 25.3% |
| Forward P/E | 11.2x | 13.4x | 21.7x | 16.8x | 26.4x |
| Total Debt | $1.30B | $43.54B | $12.31B | $8.13B | $7.14B |
| Cash & Equiv. | $19M | $10.68B | $3.04B | $2.21B | $3.71B |
VET vs XOM vs SLB vs HAL vs BKR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Vermilion Energy In… (VET) | 100 | 250.0 | +150.0% |
| Exxon Mobil Corpora… (XOM) | 100 | 328.7 | +228.7% |
| SLB N.V. (SLB) | 100 | 305.5 | +205.5% |
| Halliburton Company (HAL) | 100 | 305.1 | +205.1% |
| Baker Hughes Company (BKR) | 100 | 410.3 | +310.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VET vs XOM vs SLB vs HAL vs BKR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VET is the #2 pick in this set and the best alternative if value and dividends is your priority.
- Lower P/E (11.2x vs 26.4x)
- 4.1% yield, 3-year raise streak, vs XOM's 2.7%
XOM lags the leaders in this set but could rank higher in a more targeted comparison.
SLB is the clearest fit if your priority is income & stability.
- Dividend streak 4 yrs, beta 0.82, yield 1.9%
HAL ranks third and is worth considering specifically for sleep-well-at-night and defensive.
- Lower volatility, beta 0.37, Low D/E 77.4%, current ratio 2.04x
- Beta 0.37, yield 1.7%, current ratio 2.04x
- Beta 0.37 vs BKR's 0.83
- +83.3% vs XOM's +37.7%
BKR carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth -0.3%, EPS growth -12.8%, 3Y rev CAGR 9.4%
- 177.2% 10Y total return vs XOM's 101.3%
- -0.3% revenue growth vs VET's -15.0%
- 11.2% margin vs VET's -44.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -0.3% revenue growth vs VET's -15.0% | |
| Value | Lower P/E (11.2x vs 26.4x) | |
| Quality / Margins | 11.2% margin vs VET's -44.9% | |
| Stability / Safety | Beta 0.37 vs BKR's 0.83 | |
| Dividends | 4.1% yield, 3-year raise streak, vs XOM's 2.7% | |
| Momentum (1Y) | +83.3% vs XOM's +37.7% | |
| Efficiency (ROA) | 7.3% ROA vs VET's -13.8%, ROIC 12.7% vs 3.5% |
VET vs XOM vs SLB vs HAL vs BKR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
VET vs XOM vs SLB vs HAL vs BKR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BKR leads in 3 of 6 categories
VET leads 1 • XOM leads 0 • SLB leads 0 • HAL leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BKR leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM is the larger business by revenue, generating $323.9B annually — 178.6x VET's $1.8B. BKR is the more profitable business, keeping 11.2% of every revenue dollar as net income compared to VET's -44.9%. On growth, SLB holds the edge at +5.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.8B | $323.9B | $35.7B | $22.2B | $27.9B |
| EBITDAEarnings before interest/tax | $1.2B | $59.9B | $7.4B | $3.4B | $4.5B |
| Net IncomeAfter-tax profit | -$814M | $28.8B | $3.4B | $1.5B | $3.1B |
| Free Cash FlowCash after capex | $301M | $23.6B | $4.8B | $1.7B | $2.6B |
| Gross MarginGross profit ÷ Revenue | +35.9% | +21.7% | +18.2% | +15.3% | +23.6% |
| Operating MarginEBIT ÷ Revenue | +20.2% | +10.5% | +15.3% | +11.3% | +25.3% |
| Net MarginNet income ÷ Revenue | -44.9% | +8.9% | +9.4% | +6.9% | +11.2% |
| FCF MarginFCF ÷ Revenue | +16.6% | +7.3% | +13.4% | +7.6% | +9.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -16.4% | -1.3% | +5.0% | -0.3% | +2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -10.9% | -11.0% | -31.2% | +129.2% | +132.5% |
Valuation Metrics
VET leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 21.9x trailing earnings, XOM trades at a 17% valuation discount to HAL's 26.4x P/E. On an enterprise value basis, VET's 3.9x EV/EBITDA is more attractive than BKR's 13.9x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.7B | $623.0B | $84.3B | $33.1B | $62.6B |
| Enterprise ValueMkt cap + debt − cash | $2.6B | $655.9B | $93.6B | $39.0B | $66.0B |
| Trailing P/EPrice ÷ TTM EPS | -3.68x | 21.94x | 23.91x | 26.40x | 24.28x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.20x | 13.41x | 21.69x | 16.80x | 26.45x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 3.92x | 10.94x | 12.71x | 11.48x | 13.92x |
| Price / SalesMarket cap ÷ Revenue | 1.35x | 1.92x | 2.36x | 1.49x | 2.26x |
| Price / BookPrice ÷ Book value/share | 1.08x | 2.37x | 3.06x | 3.17x | 3.30x |
| Price / FCFMarket cap ÷ FCF | 7.32x | 26.39x | 17.59x | 19.78x | 24.68x |
Profitability & Efficiency
BKR leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
BKR delivers a 16.1% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-34 for VET. XOM carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to HAL's 0.77x. On the Piotroski fundamental quality scale (0–9), BKR scores 6/9 vs XOM's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -33.7% | +10.7% | +13.9% | +14.6% | +16.1% |
| ROA (TTM)Return on assets | -13.8% | +6.4% | +6.5% | +6.1% | +7.3% |
| ROICReturn on invested capital | +3.5% | +8.6% | +12.1% | +10.2% | +12.7% |
| ROCEReturn on capital employed | +3.3% | +8.9% | +14.3% | +11.6% | +13.6% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 | 4 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.59x | 0.16x | 0.45x | 0.77x | 0.38x |
| Net DebtTotal debt minus cash | $1.3B | $32.9B | $9.3B | $5.9B | $3.4B |
| Cash & Equiv.Liquid assets | $19M | $10.7B | $3.0B | $2.2B | $3.7B |
| Total DebtShort + long-term debt | $1.3B | $43.5B | $12.3B | $8.1B | $7.1B |
| Interest CoverageEBIT ÷ Interest expense | 2.53x | 69.44x | 9.40x | 9.19x | 9.68x |
Total Returns (Dividends Reinvested)
BKR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BKR five years ago would be worth $27,175 today (with dividends reinvested), compared to $14,136 for VET. Over the past 12 months, HAL leads with a +83.3% total return vs XOM's +37.7%. The 3-year compound annual growth rate (CAGR) favors BKR at 30.2% vs VET's 1.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +31.7% | +21.5% | +41.2% | +34.9% | +34.9% |
| 1-Year ReturnPast 12 months | +45.6% | +37.7% | +60.9% | +83.3% | +65.8% |
| 3-Year ReturnCumulative with dividends | +4.0% | +49.2% | +26.6% | +31.2% | +120.7% |
| 5-Year ReturnCumulative with dividends | +41.4% | +167.3% | +78.9% | +80.1% | +171.7% |
| 10-Year ReturnCumulative with dividends | -39.7% | +101.3% | -11.1% | +2.6% | +177.2% |
| CAGR (3Y)Annualised 3-year return | +1.3% | +14.3% | +8.2% | +9.5% | +30.2% |
Risk & Volatility
Evenly matched — XOM and SLB each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.37 beta — it tends to amplify market swings less than BKR's 0.83 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SLB currently trades 95.5% from its 52-week high vs VET's 75.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.18x | -0.37x | 0.82x | 0.37x | 0.83x |
| 52-Week HighHighest price in past year | $14.82 | $176.41 | $58.82 | $43.59 | $70.41 |
| 52-Week LowLowest price in past year | $7.00 | $105.53 | $31.64 | $20.09 | $37.38 |
| % of 52W HighCurrent price vs 52-week peak | +75.2% | +83.3% | +95.5% | +90.8% | +89.7% |
| RSI (14)Momentum oscillator 0–100 | 40.9 | 42.4 | 51.4 | 47.4 | 47.1 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 13.9M | 12.1M | 10.5M | 7.3M |
Analyst Outlook
Evenly matched — VET and XOM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: VET as "Hold", XOM as "Hold", SLB as "Buy", HAL as "Buy", BKR as "Buy". Consensus price targets imply 15.9% upside for BKR (target: $73) vs -3.7% for VET (target: $11). For income investors, VET offers the higher dividend yield at 4.10% vs BKR's 1.45%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $10.74 | $170.08 | $60.23 | $39.64 | $73.20 |
| # AnalystsCovering analysts | 10 | 55 | 66 | 64 | 45 |
| Dividend YieldAnnual dividend ÷ price | +4.1% | +2.7% | +1.9% | +1.7% | +1.4% |
| Dividend StreakConsecutive years of raises | 3 | 43 | 4 | 0 | 4 |
| Dividend / ShareAnnual DPS | $0.64 | $4.00 | $1.08 | $0.69 | $0.92 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.5% | +3.3% | +2.9% | +3.0% | +0.6% |
BKR leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). VET leads in 1 (Valuation Metrics). 2 tied.
VET vs XOM vs SLB vs HAL vs BKR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VET or XOM or SLB or HAL or BKR a better buy right now?
For growth investors, Baker Hughes Company (BKR) is the stronger pick with -0.
3% revenue growth year-over-year, versus -15. 0% for Vermilion Energy Inc. (VET). Exxon Mobil Corporation (XOM) offers the better valuation at 21. 9x trailing P/E (13. 4x forward), making it the more compelling value choice. Analysts rate SLB N. V. (SLB) a "Buy" — based on 66 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VET or XOM or SLB or HAL or BKR?
On trailing P/E, Exxon Mobil Corporation (XOM) is the cheapest at 21.
9x versus Halliburton Company at 26. 4x. On forward P/E, Vermilion Energy Inc. is actually cheaper at 11. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — VET or XOM or SLB or HAL or BKR?
Over the past 5 years, Baker Hughes Company (BKR) delivered a total return of +171.
7%, compared to +41. 4% for Vermilion Energy Inc. (VET). Over 10 years, the gap is even starker: BKR returned +177. 2% versus VET's -39. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VET or XOM or SLB or HAL or BKR?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
37β versus Baker Hughes Company's 0. 83β — meaning BKR is approximately -323% more volatile than XOM relative to the S&P 500. On balance sheet safety, Exxon Mobil Corporation (XOM) carries a lower debt/equity ratio of 16% versus 77% for Halliburton Company — giving it more financial flexibility in a downturn.
05Which is growing faster — VET or XOM or SLB or HAL or BKR?
By revenue growth (latest reported year), Baker Hughes Company (BKR) is pulling ahead at -0.
3% versus -15. 0% for Vermilion Energy Inc. (VET). On earnings-per-share growth, the picture is similar: Baker Hughes Company grew EPS -12. 8% year-over-year, compared to -1313. 3% for Vermilion Energy Inc.. Over a 3-year CAGR, BKR leads at 9. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VET or XOM or SLB or HAL or BKR?
SLB N.
V. (SLB) is the more profitable company, earning 9. 4% net margin versus -37. 0% for Vermilion Energy Inc. — meaning it keeps 9. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SLB leads at 15. 3% versus 9. 5% for VET. At the gross margin level — before operating expenses — BKR leads at 23. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VET or XOM or SLB or HAL or BKR more undervalued right now?
On forward earnings alone, Vermilion Energy Inc.
(VET) trades at 11. 2x forward P/E versus 26. 4x for Baker Hughes Company — 15. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BKR: 15. 9% to $73. 20.
08Which pays a better dividend — VET or XOM or SLB or HAL or BKR?
All stocks in this comparison pay dividends.
Vermilion Energy Inc. (VET) offers the highest yield at 4. 1%, versus 1. 4% for Baker Hughes Company (BKR).
09Is VET or XOM or SLB or HAL or BKR better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
37), 2. 7% yield, +101. 3% 10Y return). Both have compounded well over 10 years (XOM: +101. 3%, SLB: -11. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VET and XOM and SLB and HAL and BKR?
Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: VET is a small-cap income-oriented stock; XOM is a large-cap quality compounder stock; SLB is a mid-cap quality compounder stock; HAL is a mid-cap quality compounder stock; BKR is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.